{"pub": "investing.com", "url": "https://ca.investing.com/news/stock-market-news/briefintelgenx-announces-resubmission-of-rizaport-new-drug-application-1976576", "downloaded_at": "2019-09-26 21:28:30.334708+00:00", "title": "BRIEF-Intelgenx Announces Resubmission Of Rizaport New Drug Application", "language": "en", "text": "BRIEF-Intelgenx Announces Resubmission Of Rizaport New Drug Application\n\nStock Markets 48 minutes ago (Sep 26, 2019 16:40)\n\n\u00a9 Reuters. BRIEF-Intelgenx Announces Resubmission Of Rizaport New Drug Application Sept 26 (Reuters) - Intelgenx Technologies Corp : * INTELGENX ANNOUNCES RESUBMISSION OF RIZAPORT\u00ae NEW DRUG APPLICATION * INTELGENX TECHNOLOGIES - RESUBMITTED ITS 505(B)(2) NEW DRUG APPLICATION FOR RIZAPORT VERSAFILM FOR TREATMENT OF ACUTE MIGRAINES TO U.S. FDA\n\nBRIEF-Intelgenx Announces Resubmission Of Rizaport New Drug Application", "description": "BRIEF-Intelgenx Announces Resubmission Of Rizaport New Drug Application", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXNPEF102VH_L.jpg", "published_at": "2019-09-26"}